Aspire Private Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10
| Closed | -$10.5K | – | 522 |
|
|
2024
Q3 | $10.5K | Hold |
10
| – | – | ﹤0.01% | 375 |
|
|
2024
Q2 | $10.5K | Hold |
10
| – | – | ﹤0.01% | 380 |
|
|
2024
Q1 | $9.63K | Hold |
10
| – | – | ﹤0.01% | 408 |
|
|
2023
Q4 | $8.78K | Hold |
10
| – | – | ﹤0.01% | 409 |
|
|
2023
Q3 | $8.23K | Hold |
10
| – | – | ﹤0.01% | 417 |
|
|
2023
Q2 | $7.19K | Hold |
10
| – | – | ﹤0.01% | 412 |
|
|
2023
Q1 | $8.22K | Hold |
10
| – | – | ﹤0.01% | 392 |
|
|
2022
Q4 | $7.22K | Hold |
10
| – | – | ﹤0.01% | 390 |
|
|
2022
Q3 | $7K | Hold |
10
| – | – | ﹤0.01% | 388 |
|
|
2022
Q2 | $6K | Hold |
10
| – | – | ﹤0.01% | 386 |
|
|
2022
Q1 | $7K | Hold |
10
| – | – | ﹤0.01% | 367 |
|
|
2021
Q4 | $6K | Sell |
10
-20
| -67% | -$12K | ﹤0.01% | 397 |
|
|
2021
Q3 | $18K | Buy |
30
+10
| +50% | +$6K | 0.01% | 275 |
|
|
2021
Q2 | $11K | Buy |
+20
| New | +$11K | ﹤0.01% | 320 |
|
|
2021
Q1 | – | Sell |
-10
| Closed | -$5K | – | 597 |
|
|
2020
Q4 | $5K | Sell |
10
-72
| -88% | -$36K | ﹤0.01% | 304 |
|
|
2020
Q3 | $46K | Sell |
82
-24
| -23% | -$13.5K | 0.02% | 207 |
|
|
2020
Q2 | $66K | Sell |
106
-70
| -40% | -$43.6K | 0.03% | 161 |
|
|
2020
Q1 | $86K | Buy |
176
+166
| +1,660% | +$81.1K | 0.05% | 128 |
|
|
2019
Q4 | $4K | Hold |
10
| – | – | ﹤0.01% | 322 |
|
|
2019
Q3 | $3K | Hold |
10
| – | – | ﹤0.01% | 330 |
|
|
2019
Q2 | $3K | Hold |
10
| – | – | ﹤0.01% | 368 |
|
|
2019
Q1 | $4K | Hold |
10
| – | – | ﹤0.01% | 380 |
|
|
2018
Q4 | $4K | Buy |
+10
| New | +$4K | ﹤0.01% | 365 |
|